AngioDynamics Inc reports results for the quarter ended November 30 - Earnings Summary

• AngioDynamics Inc ANGO.OQ reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended November 30, higher than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of three analysts for the quarter was for a loss of 11 cents per share. Wall Street expected results to range from -12 cents to -10 cents per share.

• Revenue fell 7.9% to $72.85 million from a year ago; analysts expected $70.93 million.

• AngioDynamics Inc's reported EPS for the quarter was a loss of 26 cents​.

• The company reported a quarterly loss of $10.74 million.

• AngioDynamics Inc shares had risen by 2.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AngioDynamics Inc is $13.00

This summary was machine generated from LSEG data January 8 at 02:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)